Dr Lee Kellingray

Researcher

Contact via email

Translational microbiome

Links/websites:

I obtained a first class degree in Microbiology at the University of East Anglia in 2011, and joined the Quadram Institute Science in the same year to do a PhD looking at the effects of Brassica vegetables on the human gut microbiota. Following my PhD I joined the Translational Microbiome group as a research scientist to work with Professor Arjan Narbad to examine how pathogenic bacteria interact with the human gut microbiota, and investigate the potential of next generation sequencing as a clinical diagnostic tool.

I am currently involved in a successful collaboration with the Norfolk and Norwich University Hospital providing bacteriotherapy to patients with recurrent Clostridium difficile infection. In addition to this I am using in vitro colon models and 1H NMR to examine the effects of gut pathogens, such as Salmonella typhimurium, on the gut microbiota through metagenomic and metabolomic analyses.

My current interests are focused on the role of the gut microbiota in health, specifically host-microbe and microbe-microbe interactions, and how this research can be translated to improved health outcomes for the general public.

Parmanand B., Kellingray L., Le Gall G., Basit A., Fairweather S., Narbad A.. (2019)

A decrease in iron availability to human gut microbiome reduces the growth ofpotentially pathogenic gut bacteria; an in vitro colonic fermentation study

Journal of Nutritional Biochemistry, 67, 20-27


View Publication

Tran T. T. T., Corsini S., Kellingray L., Hegarty C., Le Gall G., Narbad A., Müller M., Tejera N., O'Toole P. W., Minihane A. M., Vauzour D.. (2019)

APOE genotype influences the gut microbiome structure and function in humans and mice: relevance for Alzheimer's disease pathophysiology.

FASEB Journal, fj201900071R


View Publication

Goldenberg S. D., Batra R., Beales I., Digby-Bell J. L., Irving P. M., Kellingray L., Narbad A., Franslem-Elumogo N.. (2018)

Comparison of Different Strategies for Providing Fecal Microbiota Transplantation to Treat Patients with Recurrent Clostridium difficile Infection in Two English Hospitals: A Review

Infectious Diseases and Therapy


View Publication

Kellingray L., Le Gall G., Defernez M., Beales I. L., Franslem-Elumogo N., Narbad A.. (2018)

Microbial taxonomic and metabolic alterations during faecal microbiota transplantation to treat Clostridium difficile infection

Journal of Infection


View Publication

Shi Y., Kellingray L., Le Gall G., Zhao J., Zhang H., Narbad A., Zhai Q., Chen W.. (2018)

The divergent restoration effects of Lactobacillus strains in antibiotic-induced dysbiosis

Journal of Functional Foods, 51, 142-152


View Publication

Le Gall G., Guttula K., Kellingray L., Tett A. J., ten Hoopen R., Kemsley E. K., Savva G. M., Ibrahim A., Narbad A.. (2018)

Metabolite quantification of faecal extracts from colorectal cancer patients and healthy controls

Oncotarget


View Publication

Related News